Indivior Pharmaceuticals (INDV) Non Operating Income (2022 - 2024)
Historic Non Operating Income for Indivior Pharmaceuticals (INDV) over the last 3 years, with Q4 2024 value amounting to -$9.0 million.
- Indivior Pharmaceuticals' Non Operating Income fell 100000.0% to -$9.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was -$19.0 million, marking a year-over-year decrease of 48000.0%. This contributed to the annual value of -$20.0 million for FY2024, which is 50000.0% down from last year.
- Latest data reveals that Indivior Pharmaceuticals reported Non Operating Income of -$9.0 million as of Q4 2024, which was down 100000.0% from -$5.0 million recorded in Q3 2024.
- Indivior Pharmaceuticals' 5-year Non Operating Income high stood at $2.0 million for Q4 2022, and its period low was -$9.0 million during Q4 2024.
- For the 3-year period, Indivior Pharmaceuticals' Non Operating Income averaged around -$1.7 million, with its median value being -$2.0 million (2022).
- As far as peak fluctuations go, Indivior Pharmaceuticals' Non Operating Income skyrocketed by 20000.0% in 2023, and later tumbled by 100000.0% in 2024.
- Indivior Pharmaceuticals' Non Operating Income (Quarter) stood at $2.0 million in 2022, then crashed by 50.0% to $1.0 million in 2023, then tumbled by 1000.0% to -$9.0 million in 2024.
- Its Non Operating Income was -$9.0 million in Q4 2024, compared to -$5.0 million in Q3 2024 and -$3.0 million in Q2 2024.